Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Squamous Cell Carcinoma of Head and Neck 16Oropharyngeal Neoplasms 10Nasopharyngeal Carcinoma 10Prostatic Neoplasms 7Laryngeal Neoplasms 6Rectal Neoplasms 5Mouth Neoplasms 5Hypopharyngeal Neoplasms 5Head and Neck Neoplasms 5Carcinoma 5Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nasopharyngeal Neoplasms 2Mesothelioma 2Epstein-Barr Virus Infections 2Carcinoma, Intraductal, Noninfiltrating 2Astrocytoma 2Anus Neoplasms 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomatitis 1Stomach Neoplasms 1

Interventions

Cyclophosphamide 45fludarabine 32Methotrexate 24blinatumomab 20Vincristine 19Dexamethasone 19fludarabine phosphate 18Specimen Handling 17Cytarabine 17Whole-Body Irradiation 14Melphalan 13Tacrolimus 12Calcium Dobesilate 12Biopsy 12Mercaptopurine 11Busulfan 11merphos 10Peripheral Blood Stem Cell Transplantation 10Mycophenolic Acid 10Thiotepa 9Stem Cell Transplantation 9Rituximab 9Granulocyte Colony-Stimulating Factor 9Doxorubicin 9venetoclax 8ponatinib 8dexamethasone acetate 8dexamethasone 21-phosphate 8Prednisone 8Mesna 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Radiotherapy, Intensity-Modulated × 90 days × Clear all
NCT02333162 2026-03-30

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

University of Chicago

Phase 1 Suspended
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00576979 2026-03-24

Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

City of Hope Medical Center

Phase 1/2 Completed
51 enrolled 16 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡